Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01801189 · ClinicalTrials.gov registry record · Phase 4
Preoperative Pain Control in Gastric Bypass Surgery Patients
A Phase 4 study of Postoperative Pain, sponsored by Legacy Health System.
- Completed
- Registry status
- Phase 4
- Development phase
- 61
- Enrollment target
- 1
- Study location
NCT01801189: Completed Phase 4 study of Postoperative Pain, sponsored by Legacy Health System.
NCT01801189 is a Phase 4 study of Postoperative Pain that has completed, run by Legacy Health System. The registered enrollment target is 61 participants, below the 231-participant average among 120 other Postoperative Pain trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01801189, a Phase 4 study of Postoperative Pain, has completed, sponsored by Legacy Health System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 61 participants
- Enrollment target
- 1
- Study location
Study Summary
Randomized clinical trial to evaluate whether a single pre-operative dose of Pregabalin will alleviate post-operative pain and decrease post-operative analgesic requirements in morbidly obese patients undergoing laparoscopic gastric bypass surgery.
Conditions Studied
Interventions
- DRUG Pregabalin
- DRUG Placebo (for Pregabalin)
Study Locations (1)
Oregon
- Legacy Good Samaritan Medical Center - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2013-02 |
| Est. Completion | 2016-01 |
| Phase | Phase 4 |
What the finished NCT01801189 record still lists
NCT01801189 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 231-participant average among 120 other Postoperative Pain trials with a reported enrollment target (74% lower).
The record links to 1 condition, with Postoperative Pain appearing as the primary indexed condition, and to 2 interventions - of which Pregabalin is the first listed.
NCT01801189 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT01801189 about?
NCT01801189 is a clinical study titled "Preoperative Pain Control in Gastric Bypass Surgery Patients". Randomized clinical trial to evaluate whether a single pre-operative dose of Pregabalin will alleviate post-operative pain and decrease post-operative analgesic requirements in morbidly obese patients undergoing laparoscopic gastric bypass surgery.
What is the current status of trial NCT01801189?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 61 participants. The study started on 2013-02. Estimated completion is 2016-01.
What conditions does trial NCT01801189 study?
This clinical trial studies the following conditions: Postoperative Pain.
What interventions are being tested in trial NCT01801189?
The interventions under investigation include: Pregabalin (DRUG), Placebo (for Pregabalin) (DRUG).
Who is sponsoring clinical trial NCT01801189?
This trial is sponsored by Legacy Health System, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01801189 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01801189's enrollment target sits among peer trials
61 96th of 120 higher than 25 of 120 other Postoperative Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postoperative Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Paracervical Injection and Opioid Use After Vaginal Hysterectomy for Prolapse
RECRUITING · Phase 4
-
QL Block in Laparoscopic Myomectomy
RECRUITING · Phase 4
-
Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients
RECRUITING · Phase 4
-
A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi
RECRUITING · Phase 4
-
Preoperative Acetazolamide
RECRUITING · Phase 4
-
Methadone to Reduce Chronic Opioid Use After Major Spine Surgery: The MEND Pilot Feasibility Study
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia